In-hospital safety and procedural outcomes for percutaneous left atrial appendage (LAA) closure are substantially better with the Watchman FLX device than with its predecessor, new research shows.

Please provide your email address to receive an email when new articles are posted on . In a real-world analysis of registry data, researchers also found that the Watchman FLX device (Boston ...

Early results from the massive National Cardiovascular Data Registry Left Atrial Appendage Occlusion Registry indicate that the rollout of the Watchman device into routine clinical practice is going ...

In the first 3 years of the LAAO Registry, the Watchman left atrial appendage (LAA) closure device (Boston Scientific) was implanted with rates of in-hospital safety outcomes that were comparable to ...

Two newly published studies shed light on how real-world patients with atrial fibrillation fared after undergoing left atrial appendage occlusion (LAAO) with the first-generation Watchman device ...